Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gerard

Showing results (261-270 of 283) with videos related to

Pageof 29
Sort By:
International Journal of Pharmaceutics|August 4, 2025
Novel oral LAAM immediate-release capsules for treating opioid use disorderZixuan Zhen, Hadi Sudarjat, Katherine Pierce, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Neuroimaging Biomarkers in AddictionHamed Ekhtiari, Arshiya Sangchooli, Owen Carmichael, et al.
Addiction (Abingdon, England)|May 13, 2017
PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trialJoy M Schmitz, Charles E Green, Khader M Hasan, et al.
The New Phytologist|February 16, 2016
Leaf aging of Amazonian canopy trees as revealed by spectral and physiochemical measurementsCecilia Chavana-Bryant, Yadvinder Malhi, Jin Wu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 20, 2019
Convergent neural connectivity in motor impulsivity and high-fat food binge-like eating in male Sprague-Dawley ratsNoelle C Anastasio, Sonja J Stutz, Amanda E Price, et al.
Drug and Alcohol Dependence Reports|April 10, 2023
Rapid induction onto extended-release injectable buprenorphine following opioid overdose: A case seriesTaylor A Ochalek, Katy J Ringwood, Theresa T Davis, et al.
ACS Chemical Neuroscience|January 22, 2013
Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addictionKathryn A Cunningham, Noelle C Anastasio, Robert G Fox, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 28, 2013
Biomarkers for the development of new medications for cocaine dependenceKristopher J Bough, Shashi Amur, Guifang Lao, et al.
Frontiers in Psychiatry|June 2, 2012
Increased Orbitofrontal Brain Activation after Administration of a Selective Adenosine A(2A) Antagonist in Cocaine Dependent SubjectsF Gerard Moeller, Joel L Steinberg, Scott D Lane, et al.
Journal of Clinical and Translational Science|May 30, 2023
Use of population health data to promote equitable recruitment for a primary care practice implementation trial addressing unhealthy alcohol useAlex H Krist, Alison N Huffstetler, Gabriela Villalobos, et al.
Pageof 29

Showing results (261-270 of 283) with videos related to

Sort By:
Pageof 29
International Journal of Pharmaceutics|August 4, 2025
Novel oral LAAM immediate-release capsules for treating opioid use disorderZixuan Zhen, Hadi Sudarjat, Katherine Pierce, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Neuroimaging Biomarkers in AddictionHamed Ekhtiari, Arshiya Sangchooli, Owen Carmichael, et al.
Addiction (Abingdon, England)|May 13, 2017
PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trialJoy M Schmitz, Charles E Green, Khader M Hasan, et al.
The New Phytologist|February 16, 2016
Leaf aging of Amazonian canopy trees as revealed by spectral and physiochemical measurementsCecilia Chavana-Bryant, Yadvinder Malhi, Jin Wu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 20, 2019
Convergent neural connectivity in motor impulsivity and high-fat food binge-like eating in male Sprague-Dawley ratsNoelle C Anastasio, Sonja J Stutz, Amanda E Price, et al.
Drug and Alcohol Dependence Reports|April 10, 2023
Rapid induction onto extended-release injectable buprenorphine following opioid overdose: A case seriesTaylor A Ochalek, Katy J Ringwood, Theresa T Davis, et al.
ACS Chemical Neuroscience|January 22, 2013
Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addictionKathryn A Cunningham, Noelle C Anastasio, Robert G Fox, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 28, 2013
Biomarkers for the development of new medications for cocaine dependenceKristopher J Bough, Shashi Amur, Guifang Lao, et al.
Frontiers in Psychiatry|June 2, 2012
Increased Orbitofrontal Brain Activation after Administration of a Selective Adenosine A(2A) Antagonist in Cocaine Dependent SubjectsF Gerard Moeller, Joel L Steinberg, Scott D Lane, et al.
Journal of Clinical and Translational Science|May 30, 2023
Use of population health data to promote equitable recruitment for a primary care practice implementation trial addressing unhealthy alcohol useAlex H Krist, Alison N Huffstetler, Gabriela Villalobos, et al.
Pageof 29